The prospective association between psychological distress and disease activity in rheumatoid arthritis: A multilevel regression analysis

Annals of the Rheumatic Diseases

Volumn 71, Issue 2, 2012, Pages 192-197

  Overman, Cécile L ^a   Bossema, Ercolie R ^a   Van Middendorp, Henriët ^a   Wijngaards De Meij, Leoniek ^a   Verstappen, Suzanne M M ^b   Bulder, Marcia ^a   Jacobs, Johannes W G ^c   Bijlsma, Johannes W J ^c   Geenen, Rinie ^a,c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

RHEUMATOID FACTOR;

ADULT; AGED; ANXIETY; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; DISTRESS SYNDROME; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; REGRESSION ANALYSIS; RHEUMATOID ARTHRITIS; SCORING SYSTEM; THOMPSON JOINT SCORE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANXIETY; ARTHRITIS, RHEUMATOID; BLOOD SEDIMENTATION; DEPRESSION; DISEASE PROGRESSION; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RHEUMATOID FACTOR; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 84855357035     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-200338     Document Type: Article

References (57)

1. Matthews G. Distress. In: Fink G, ed. Encyclopedia of Stress. Vol. 1. San Diego, CA: Academic Press 2000:723-9.
2. Abdel-Nasser AM, Abd El-Azim S, Taal E, et al. Depression and depressive symptoms in rheumatoid arthritis patients: an analysis of their occurrence and determinants. Br J Rheumatol 1998;37:391-7.
3. Creed F. Psychological disorders in rheumatoid arthritis: a growing consensus? Ann Rheum Dis 1990;49:808-12. (Pubitemid 20346392)
4. Dickens C, McGowan L, Clark-Carter D, et al. Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis. Psychosom Med 2002;64:52-60. (Pubitemid 34137399)
5. Pincus T, Griffith J, Pearce S, et al. Prevalence of self-reported depression in patients with rheumatoid arthritis. Br J Rheumatol 1996;35:879-83.
6. Smedstad LM, Moum T, Vaglum P, et al. The impact of early rheumatoid arthritis on psychological distress. A comparison between 238 patients with RA and 116 matched controls. Scand J Rheumatol 1996;25:377-82.
7. Covic T, Tyson G, Spencer D, et al. Depression in rheumatoid arthritis patients: demographic, clinical, and psychological predictors. J Psychosom Res 2006;60:469-76.
8. Frank RG, Beck NC, Parker JC, et al. Depression in rheumatoid arthritis. J Rheumatol 1988;15:920-5.
9. Isik A, Koca SS, Ozturk A, et al. Anxiety and depression in patients with rheumatoid arthritis. Clin Rheumatol 2007;26:872-8. (Pubitemid 46951281)
10. Margaretten M, Yelin E, Imboden J, et al. Predictors of depression in a multiethnic cohort of patients with rheumatoid arthritis. Arthritis Rheum 2009;61:1586-91.
11. Wiltink J, Beutel ME, Till Y, et al. Prevalence of distress, comorbid conditions and well being in the general population. J Affect Disord 2011;130:429-37.
12. VanDyke MM, Parker JC, Smarr KL, et al. Anxiety in rheumatoid arthritis. Arthritis Rheum 2004;51:408-12. (Pubitemid 38725140)
13. Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:617-27. (Pubitemid 40973437)
14. Geenen R, Van Middendorp H, Bijlsma JW. The impact of stressors on health status and hypothalamic - pituitary - adrenal axis and autonomic nervous system responsiveness in rheumatoid arthritis. Ann NY Acad Sci 2006;1069:77-97. (Pubitemid 43989852)
15. Kiecolt-Glaser JK, McGuire L, Robles TF, et al. Emotions, morbidity, and mortality: new perspectives from psychoneuroimmunology. Annu Rev Psychol 2002;53:83-107.
16. Barden N. Implication of the hypothalamic - pituitary - adrenal axis in the physiopathology of depression. J Psychiatry Neurosci 2004;29:185-93. (Pubitemid 38829855)
17. Claes SJ. CRH, stress, and major depression: a psychobiological interplay. Vitam Horm 2004;69:117-50. (Pubitemid 39753924)
18. Maes M, Bosmans E, Meltzer HY, et al. Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression? Am J Psychiatry 1993;150:1189-93. (Pubitemid 23218899)
19. Miller GE, Cohen S, Ritchey AK. Chronic psychological stress and the regulation of pro-inflammatory cytokines: a glucocorticoid-resistance model. Health Psychol 2002;21:531-41. (Pubitemid 35244766)
20. Pariante CM. Depression, stress and the adrenal axis. J Neuroendocrinol 2003;15:811-12. (Pubitemid 36874378)
21. Dentino AN, Pieper CF, Rao MK, et al. Association of interleukin-6 and other biologic variables with depression in older people living in the community. J Am Geriatr Soc 1999;47:6-11. (Pubitemid 29044260)
22. Maes M, Meltzer HY, Bosmans E, et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 1995;34:301-9.
23. Maes M, Vandoolaeghe E, Ranjan R, et al. Increased serum interleukin-1-receptor-antagonist concentrations in major depression. J Affect Disord 1995;36:29-36. (Pubitemid 26020970)
24. Maes M, Song C, Lin A, et al. The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine 1998;10:313-18. (Pubitemid 28227076)
25. Zhou D, Kusnecov AW, Shurin MR, et al. Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic - pituitary - adrenal axis. Endocrinology 1993;133:2523-30. (Pubitemid 24000698)
26. Pace TW, Hu F, Miller AH. Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun 2007;21:9-19. (Pubitemid 44872932)
27. Raison CL, Miller AH. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry 2003;160:1554-65. (Pubitemid 41079539)
28. Kiecolt-Glaser JK, Glaser R. Methodological issues in behavioral immunology research with humans. Brain Behav Immun 1988;2:67-78.
29. Geenen R, Mulligan K, Shipley M, et al. Psychosocial dimensions of the rheumatic diseases. In: Bijlsma JWJ, Da Silva J, Faarvang KL, Burmeister G, Hachulla E, Mariette X, eds. EULAR Compendium on Rheumatic Diseases. London: BMJ Publishing Group, 2009:637-50.
30. Anisman H, Merali Z. Anhedonic and anxiogenic effects of cytokine exposure. Adv Exp Med Biol 1999;461:199-233.
31. Frenois F, Moreau M, O'Connor J, et al. Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology 2007;32:516-31. (Pubitemid 46756007)
32. Yirmiya R. Endotoxin produces a depressive-like episode in rats. Brain Res 1996;711:163-74. (Pubitemid 26080239)
33. Capuron L, Gumnick JF, Musselman DL, et al. Neurobehavioral effects of interferonalpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 2002;26:643-52. (Pubitemid 34260983)
34. Capuron L, Miller AH. Cytokines and psychopathology: lessons from interferonalpha. Biol Psychiatry 2004;56:819-24.
35. Meyers CA. Mood and cognitive disorders in cancer patients receiving cytokine therapy. Adv Exp Med Biol 1999;461:75-81.
36. Maier SF, Watkins LR. Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock. Brain Res 1995;695:279-82.
37. Evers AW, Kraaimaat FW, Geenen R, et al. Determinants of psychological distress and its course in the first year after diagnosis in rheumatoid arthritis patients. J Behav Med 1997;20:489-504. (Pubitemid 27524179)
38. Affleck G, Pfeiffer C, Tennen H, et al. Attributional processes in rheumatoid arthritis patients. Arthritis Rheum 1987;30:927-31. (Pubitemid 17140859)
39. Hider SL, Tanveer W, Brownfield A, et al. Depression in RA patients treated with anti-TNF is common and under-recognized in the rheumatology clinic. Rheumatology (Oxford) 2009;48:1152-4.
40. Odegård S, Finset A, Mowinckel P, et al. Pain and psychological health status over a 10-year period in patients with recent onset rheumatoid arthritis. Ann Rheum Dis 2007;66:1195-201. (Pubitemid 47309737)
41. Bijlsma JW, Huiskes CJ, Kraaimaat FW, et al. Relation between patients' own health assessment and clinical and laboratory findings in rheumatoid arthritis. J Rheumatol 1991;18:650-3.
42. Lutgendorf SK, Garand L, Buckwalter KC, et al. Life stress, mood disturbance, and elevated interleukin-6 in healthy older women. J Gerontol A Biol Sci Med Sci 1999;54:M434-9. (Pubitemid 29489847)
43. Nabi H, Singh-Manoux A, Shipley M, et al. Do psychological factors affect inflammation and incident coronary heart disease: the Whitehall II Study. Arterioscler Thromb Vasc Biol 2008;28:1398-406.
44. Steptoe A, Kunz-Ebrecht SR, Owen N. Lack of association between depressive symptoms and markers of immune and vascular inflammation in middle-aged men and women. Psychol Med 2003;33:667-74. (Pubitemid 36626048)
45. Verstappen SM, Jacobs JW, Bijlsma JW, et al. Five-year followup of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year. Arthritis Rheum 2003;48:1797-807. (Pubitemid 36828673)
46. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. (Pubitemid 18091653)
47. Huiskes CJAE, Kraaimaat FW, Bijlsma JWJ. Measuring health status in rheumatoid arthritis: development and refinement of a Dutch health status instrument. Gedrag en Gezondheid 1990;18:78-89.
48. Spielberger CD, Gorsuch RL, Lushene RE. Manual of the State - Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press, 1970.
49. Van der Ploeg HM, Defares PB, Spielberger CD. Handleiding bij de ZelfBeoordelingsVragenlijst ZBV. Lisse: Swets and Zeitlinger, 1980.
50. Zwart F, Spooren J. Ontwikkeling van een Zelfbeoordelingsvragenlijst Voor Depressie (Development of a self-report questionnaire for depression). Utrecht: University Medical Center Utrecht, 1982.
51. Thompson PW, Silman AJ, Kirwan JR, et al. Articular indices of joint inflammation in rheumatoid arthritis. Correlation with the acute-phase response. Arthritis Rheum 1987;30:618-23. (Pubitemid 17104900)
52. Raudenbush SW, Bryk AS, Cheong YF, et al. HLM 6: Hierarchical Linear and Nonlinear Modeling. Lincolnwood, IL: Scientific Software International, 2004. 53. van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 2000;27:261-3.
53. Hox J. Multilevel Analysis: Techniques and Applications. Mahwah, NJ: Lawrence Erlbaum Associates, 2002.
54. Dowdy SW, Dwyer KA, Smith CA, et al. Gender and psychological well-being of persons with rheumatoid arthritis. Arthritis Care Res 1996;9:449-56. (Pubitemid 27036041)
55. Radovits BJ, Fransen J, van Riel PL, et al. Influence of age and gender on the 28-joint Disease Activity Score (DAS28) in rheumatoid arthritis. Ann Rheum Dis 2008;67:1127-31.
56. Miller GE, Rohleder N, Cole SW. Chronic interpersonal stress predicts activation of pro- and anti-inflammatory signaling pathways 6 months later. Psychosom Med 2009;71:57-62.
57. Smolen JS, Aletaha D, Bijlsma JW, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010;69:631-7.